Published September 6, 2019
| Version v2
Dataset
Open
PROTAC virtual screening: A retrospective screening exercise
Description
My goal is to test whether retrospective virtual screening approaches can guide the design of PROTACs. As a first step, I showed that HADDOCK was the best protein-protein docking tool among those I tested to predict how E3 ligases interact with their protein substrates. Here, I ask whether docking virtual libraries of PROTAC candidates to these E3 ligase – substrate protein interfaces can be used to predict which PROTACs are active.
Notes
Funding Acknowledgment: The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation, and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
190906_Zenodo.pdf
Files
(4.3 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:f767d9111a3c98337e1563b17e2ddf71
|
5.3 kB | Download |
|
md5:b531be6116e349d8e0513a5a18ff5082
|
4.3 MB | Preview Download |